CHRS - Coherus BioSciences, Inc.

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Currency in USD
Earnings estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts6555
Avg. Estimate-0.62-0.32-1.80.8
Low estimate-1.03-0.41-2.330.29
High estimate-0.45-0.15-1.352.58
Year ago EPS-0.47-0.96-3.02-1.8
Revenue estimateCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
No. of analysts9997
Avg. Estimate54.87M84.55M299.2M581.17M
Low estimate42.05M67.94M285M480.96M
High estimate78M101M330.3M704M
Year ago sales60.15M56.91M211.04M299.2M
Sales growth (year/est)-8.80%48.60%41.80%94.20%
Earnings history29/06/202229/09/202230/12/202230/03/2023
Est. EPS-0.64-0.57-0.84-0.57
Actual EPS-0.47-0.96-0.6-0.75
Difference0.17-0.390.24-0.18
Surprise %26.60%-68.40%28.60%-31.60%
EPS trendCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Current estimate-0.62-0.32-1.80.8
7 days ago-0.63-0.33-1.840.81
30 days ago-0.39-0.27-1.20.68
60 days ago-0.39-0.22-1.320.63
90 days ago-0.41-0.16-1.510.86
EPS revisionsCurrent qtr. (Jun 2023)Next qtr. (Sep 2023)Current year (2023)Next year (2024)
Up last 7 days222N/A
Up last 30 days232N/A
Down last 7 daysN/AN/AN/AN/A
Down last 30 days1113
Growth estimatesCHRSIndustrySector(s)S&P 500
Current qtr.-31.90%N/AN/AN/A
Next qtr.66.70%N/AN/AN/A
Current year40.40%N/AN/AN/A
Next year144.40%N/AN/AN/A
Next 5 years (per annum)-25.10%N/AN/AN/A
Past 5 years (per annum)N/AN/AN/AN/A